Cavion
is a clinical-stage biotechnology company that researches and develops therapies for the treatment of chronic and neurological diseases... Read moreCavion
is a clinical-stage biotechnology company that researches and develops therapies for the treatment of chronic and neurological diseases... Read more
CEO
Add
News
Aug 13, 2019
The Business Journals
Cavion: Jazz buys Virginia biotech firm in deal valued at up to $312.5M
Apr 24, 2019
BioPortfolio
Cavion: Cavion to Present Results of Phase 2 Essential Tremor Clinical Trial in Platform Presentation at the American Academy of Neurology
Nov 05, 2018
PharmiWeb
Cavion: Cavion's T-Type Calcium Channel Modulator CX-8998 is Superior to Current Standard of Care in Suppressing Absence Seizures in a Genetic Epilepsy Model
Oct 08, 2018
BioCentury
Cavion: Cavion planning Phase III for essential tremor candidate despite Phase II miss
Oct 06, 2018
4-traders
Cavion: Cavion Announces Promising Phase 2 Data for Essential Tremor in T-CALM Proof-of-Concept Study
Aug 16, 2018
BioPortfolio
Cavion: Cavion LLC Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13042018 Prices from USD $250
Apr 19, 2018
BioPortfolio
Cavion: Cavion to Present Data Highlighting Companys Pipeline in Neurological Disorders at 70th American Academy of Neurology AAN Annual Meeting
Mar 20, 2018
PharmiWeb
Cavion: First Patient Enrolled in Cavion Multi-Center Phase 2 Clinical Trial in Epilepsy
Mar 11, 2018
BioPortfolio
Cavion: Cavion LLC Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 27022018 Prices from USD $250
Sep 22, 2017
BioPortfolio
Cavion: Cavion Enrolls 1st Patient in MultiCenter Phase 2 Clinical Trial in Essential Tremor
Cavion Competitors
1
2
3
4
5
6
7
8
9
10